Correlating Ki67 and other prognostic markers with Oncotype DX recurrence score in early oestrogen receptor positive breast cancer

AIM: Decisions regarding adjuvant chemotherapy for early breast cancer are complex. Ki67 is increasingly used, in conjunction with conventional prognostic markers, to help decide the use of adjuvant chemotherapy for early breast cancer. Ki67 has been proposed as an economical alternative to Oncotype...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Asia Pac J Clin Oncol
Main Authors: Tan, Aaron C., Li, Bob T., Nahar, Kazi, Danieletto, Suzanne, Fong, Eva S., Currer, Trevor, Parasyn, Andrew, Middleton, Philip, Wong, Heidi, Smart, Denis, Rutovitz, Josie J., McCloud, Philip, Hughes, T. Michael, Marx, Gavin M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8075631/
https://ncbi.nlm.nih.gov/pubmed/28960862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajco.12779
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados